Multi-Parameter Single-Cell Analysis,High-Speed Cell Sorting, and Multiplex Protein Quantification
Creative Proteomics provides a comprehensive flow cytometry platform for single-cell analysis, cell sorting, and multiplex protein detection supporting molecular interaction research, immunophenotyping, and functional cell-based assays. Our platform integrates BD ARIA3 Fusion and BD Symphony cytometers with up to 15+ fluorescence parameters, enabling high-dimensional immunophenotyping, receptor occupancy measurement, phospho-specific signaling analysis, and cytometric bead array (CBA) multiplex protein quantification.
Flow cytometry delivers single-cell resolution for drug discovery and biomedical research through four complementary capabilities: receptor occupancy assays for target engagement quantification, phospho-flow cytometry for signaling pathway analysis, FRET-based detection of protein-protein interactions in live cells, and cytometric bead array (CBA) multiplexing — quantifying up to 30 soluble proteins from as little as 25 µL of sample. Integrated with FACS cell sorting for downstream single-cell genomics and proteomics, the platform provides functional, cell-based validation that bridges the gap between in vitro biophysical data and cellular mechanism of action.
Core Capabilities:
Flow cytometry is a laser-based technology that simultaneously measures multiple physical and chemical characteristics of single particles — typically cells — as they pass through a focused light beam in a fluid stream. Parameters measured include cell size (forward scatter), granularity (side scatter), and fluorescence intensity from labeled antibodies, fluorescent proteins, or chemical probes. Modern flow cytometers can analyze thousands of cells per second while resolving 15 or more distinct fluorescence parameters per cell.
For molecular interaction research, flow cytometry provides unique capabilities beyond traditional biophysical techniques. FRET-based flow cytometry detects protein-protein interactions in intact cells. Cytometric bead arrays (CBA) enable multiplexed, bead-based immunoassay quantification of up to 30 soluble proteins from minimal sample volumes — combining the throughput of Luminex-style multiplexing with standard flow cytometry instrumentation. Phospho-flow cytometry measures signaling pathway activation at single-cell resolution through phospho-specific antibody staining.
Flow cytometry has become a core analytical platform in drug development, supporting the full pipeline — from early discovery immunophenotyping through clinical-stage receptor occupancy and pharmacodynamic biomarker analysis.
If your research requires single-cell resolution, multiplex protein quantification, or functional cell-based analysis — flow cytometry provides data that ensemble biophysical techniques cannot deliver.
Flow cytometry supports multiple stages of drug development and biomedical research — from early discovery through clinical biomarker analysis.
| Application Area | Flow Cytometry Approach | Key Output |
| Immuno-Oncology Drug Development | 15-color immunophenotyping + receptor occupancy (RO) + phospho-flow signaling | Immune cell subset quantification; target engagement confirmation (RO %); pathway modulation evidence |
| Cell & Gene Therapy | CAR-T kinetics & persistence monitoring; cytokine release (CBA); FACS sorting for manufacturing QC | CAR+ cell enumeration over time; multiplex cytokine profile; purified cell populations for downstream QC |
| Autoimmune & Inflammation Research | Deep immunophenotyping (T/B/NK/myeloid panels); intracellular cytokine staining; CBA multiplex | Disease-associated immune signatures; treatment response biomarkers; soluble mediator profiles |
| Infectious Disease & Vaccine Research | Antigen-specific T cell detection; B cell & plasma cell phenotyping; CBA cytokine profiling | Vaccine-elicited immune response quantification; correlates of protection; immune memory profiling |
| Protein Degrader (PROTAC/Molecular Glue) Development | Intracellular target protein quantification; receptor occupancy; phospho-flow for pathway readout | Target degradation kinetics (% remaining); ternary complex functional consequence; dose-response relationships |
| Biomarker Discovery & Translational Medicine | High-dimensional immunophenotyping (tSNE/UMAP); rare cell detection; phospho-flow PD markers | Novel immune signatures; pharmacodynamic biomarkers; patient stratification algorithms |
Each service below leverages a specific capability of multi-parameter flow cytometry to answer a distinct category of research questions. From high-dimensional immunophenotyping through single-cell protein interaction detection, methods are selected and panels designed based on your specific experimental goals.
BD ARIA3 Fusion & BD Symphony Flow Cytometry Platform
Our platform combines the BD ARIA3 Fusion high-speed cell sorter with the BD Symphony high-parameter analyzer, providing a complete workflow from multi-parameter immunophenotyping through aseptic cell sorting for downstream single-cell omics. All instruments are maintained under documented QC protocols with daily performance tracking and spectral compensation matrices validated per experimental panel.
| Instrumentation | |
| Cell Sorters | BD ARIA3 Fusion, BD ARIA 2 — high-speed aseptic sorting; 4-way sorting into tubes, plates, slides |
| Analyzers | BD Symphony — 15+ fluorescence parameters; high-throughput acquisition with 96/384-well plate loader |
| Performance Parameters | |
| Fluorescence Parameters | 15+ simultaneous detection channels covering UV (355 nm) through far-red (640 nm) excitation |
| Acquisition Speed | Up to 70,000 events/second; rare event detection at sub-0.01% frequency |
| Sorting Modes | Single-cell, purity, and yield modes; 4-way sorting; index sorting with per-cell data recording |
| Sorting Formats | 96-well, 384-well, 1536-well plates; microscope slides; 1.5 mL and 5 mL collection tubes |
| CBA Multiplexing | Up to 30 analytes per sample; 25-50 µL sample volume; sub-pg/mL to ng/mL sensitivity |
| Analysis Software | FlowJo, FCS Express for manual gating; FlowSOM, tSNE, UMAP for high-dimensional analysis |
BD ARIA3 Fusion & Symphony Platform
15+ Parameter High-Dimensional Analysis
BD Symphony and BD ARIA3 Fusion cytometers support 15 or more simultaneous fluorescence parameters per cell. Deep immunophenotyping panels resolve major immune lineages alongside activation, differentiation, and functional markers in a single tube — matching the highest panel complexity standards in the industry.
Integrated Cell Sorting + Downstream Analysis
High-speed FACS (fluorescence-activated cell sorting) isolates specific cell populations into 96/384-well plates, slides, or collection tubes under aseptic conditions. Sorted cells are immediately compatible with single-cell RNA-seq, proteomics, functional assays, or clonal expansion — no additional handling between sorting and downstream analysis.
CBA Multiplex Protein Quantification
Cytometric bead array technology quantifies up to 30 soluble proteins (cytokines, chemokines, growth factors) from 25-50 µL of serum, plasma, or culture supernatant — using standard flow cytometry instrumentation. This bridges the gap between single-analyte ELISA and dedicated multiplex platforms, providing flexible, cost-effective multiplexing.
FRET-Based Protein Interaction Detection in Live Cells
FRET (Förster Resonance Energy Transfer) by flow cytometry detects protein-protein interactions in their native cellular environment. Unlike in vitro binding assays, FRET flow cytometry reveals whether two proteins interact under physiological conditions, in the correct subcellular compartment, and in the presence of endogenous regulatory factors.
| Feature | Flow Cytometry | ELISA | Western Blot |
| Resolution | Single-cell — resolves population heterogeneity | Bulk — population average | Bulk — population average |
| Multiplex Capability | 15+ parameters simultaneously (surface + intracellular + CBA soluble) | 1 analyte per assay | 1-3 proteins per blot (stripping/reprobing) |
| Sample Required | 105-106 cells per condition; 25-50 µL for CBA | 100-200 µL per analyte | 10-50 µg protein per lane |
| Protein Interaction Detection | FRET-based interaction in live cells; RO for target engagement | Requires sandwich pair (capture + detection antibodies) | Co-IP required; post-lysis interaction only |
| Data Type | Quantitative + spatial (per-cell distribution) | Quantitative (concentration) | Semi-quantitative (band intensity) |
| Best For | Population heterogeneity, rare cell detection, functional single-cell analysis, multiplex soluble protein quantification | High-sensitivity single-analyte quantification | Protein expression confirmation, PTM detection, Co-IP validation |
| Sample Type | Requirements |
| Whole Blood / PBMCs | 1-5 mL whole blood collected in EDTA or heparin tubes; process within 6 hours for optimal viability; PBMC isolation available upon request |
| Cultured Cell Lines | Minimum 1 x 105 cells per condition; viability >80% required; provide culture medium and passage details |
| Tissue-Derived Cells | Fresh tissue for dissociation; minimum ~100 mg tissue; dissociation protocol optimized per tissue type; viability assessment included |
| Serum / Plasma / Supernatant (CBA) | 25-50 µL per sample; collect in standard collection tubes; avoid hemolysis; store at -80°C for long-term storage |
| Cell Number for Sorting | Starting population: 1 x 106 to 1 x 107 total cells depending on target population frequency; higher input for rare populations |
| Shipping | Fresh samples: ship on cold packs, overnight delivery; fixed samples: compatible with 1-4% PFA fixation; cryopreserved cells: ship on dry ice |
Panel design consultation is included with every project. Our team works with you to select fluorophore-antibody combinations that maximize resolution while minimizing spectral overlap — ensuring your panel generates interpretable, publication-quality data from the first experiment.
From Raw Data to Publication-Ready Analysis
Every flow cytometry project includes a complete data package with gating strategy documentation, quantitative results, and expert interpretation.
Gating Strategy & Population Analysis
Sequential gating hierarchy documented with population statistics. FCS files with FlowJo workspace for independent re-analysis.
Quantitative Results & Statistics
Tabulated cell frequencies, MFI values, receptor occupancy percentages, and CBA protein concentrations with statistical comparisons across experimental groups.
High-Dimensional Data Visualization
tSNE / UMAP plots for large-panel studies. Heatmaps and dose-response curves for functional assays. Publication-quality figures.
How many fluorescence parameters can you measure simultaneously?
Our BD Symphony analyzer supports 15+ simultaneous fluorescence parameters per cell. For deep immunophenotyping panels, we routinely design 10-15 color panels that resolve major immune lineages alongside activation, differentiation, and functional markers. Panel design consultation is included to optimize fluorophore-antibody combinations for your specific targets and experimental goals.
What types of samples can be analyzed by flow cytometry?
We accept whole blood, isolated PBMCs, cultured cell lines, fresh tissue for dissociation, cryopreserved cells, bone marrow aspirates, and cell culture supernatants (for CBA analysis). Specific handling requirements vary by sample type — whole blood should be processed within 6 hours, cryopreserved cells shipped on dry ice, and tissue samples provided fresh for optimized dissociation protocols.
What is the difference between a cell analyzer and a cell sorter?
Cell analyzers (BD Symphony) measure fluorescence parameters and count cells, providing population statistics only. Cell sorters (BD ARIA3 Fusion) physically isolate specific cell populations into collection vessels based on user-defined gating criteria — enabling downstream single-cell genomics, proteomics, or functional assays on purified populations. Our platform includes both capabilities so you can analyze first, then sort the populations of interest.
How does CBA multiplexing compare to ELISA or Luminex?
Cytometric Bead Array (CBA) quantifies up to 30 soluble proteins simultaneously from 25-50 µL of sample using standard flow cytometry instrumentation. Compared to ELISA (1 analyte per 100-200 µL), CBA provides higher throughput and lower sample consumption. Compared to Luminex, CBA uses the same bead-based multiplex principle but runs on flow cytometers rather than dedicated Luminex readers — making it a flexible, cost-effective option when flow cytometry is already part of your analytical workflow.
Can flow cytometry detect protein-protein interactions?
Yes. FRET (Förster Resonance Energy Transfer) by flow cytometry detects protein-protein interactions in intact, living cells. Unlike in vitro techniques such as SPR or ITC, FRET flow cytometry reveals whether two proteins interact under physiological conditions — in the correct subcellular compartment and in the presence of endogenous regulatory factors. This is particularly valuable for validating interactions identified by AP-MS, BioID, or yeast two-hybrid screening.
What is receptor occupancy and why is it important?
Receptor occupancy (RO) measures the percentage of target receptors on cell surfaces that are bound by a therapeutic antibody. RO assays use two antibody clones: one that competes with the drug (measuring free receptors) and one that binds a different epitope (measuring total receptors). RO data directly informs dose selection, confirms target engagement, and supports PK/PD modeling. Flow cytometry-based RO is the industry-standard method for preclinical through clinical-stage target engagement assessment.
Maecker, H.T. et al. (2012). Standardizing immunophenotyping for the Human Immunology Project. Nature Reviews Immunology. 12(3):191-200. DOI: 10.1038/nri3158
Krutzik, P.O. & Nolan, G.P. (2006). Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nature Methods. 3(5):361-368. DOI: 10.1038/nmeth872
Morgan, E. et al. (2004). Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clinical Immunology. 110(3):252-266. DOI: 10.1016/j.clim.2003.11.017
Sigalov, A.B. (2015). Flow cytometry and multiplex analysis: New approaches for the study of signal transduction. Frontiers in Immunology. 6:120. DOI: 10.3389/fimmu.2015.00120
Perfetto, S.P. et al. (2004). Seventeen-colour flow cytometry: unravelling the immune system. Nature Reviews Immunology. 4(8):648–655. DOI: 10.1038/nri1416
— Established the technical foundation for high-parameter immunophenotyping by demonstrating simultaneous detection of 17 fluorescence colors.
Irish, J.M. et al. (2004). Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 118(2):217–228. DOI: 10.1016/j.cell.2004.06.028
— Pioneered single-cell phospho-flow cytometry, demonstrating that signaling states can be resolved at individual cell resolution — the core principle underlying phospho-flow service applications.
Amir, E.D. et al. (2013). viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nature Biotechnology. 31(6):545–552. DOI: 10.1038/nbt.2594
— Introduced tSNE-based visualization for high-dimensional cytometry data, now a standard analytical component of multi-parameter flow cytometry deliverables.
Online Inquiry